August 31, 1961
Michael Yang was born.
Documentaries, videos and podcasts
June 9, 2021
ViaCyte snagged $45 million in a new tranche of financing to expand on a 2018 series D worth $80 million. The money will fund the biotech's work on two midstage candidates for type 1 diabetes, and it comes just a day after the biotech said its chief scientific officer is leaving.
Be the first contributor by making edits